Capital Ltd. Efficacy is 10% at REPROS THERAPEUTICS INC. (RPRX). They have made 8 open-market trades across 2 companies since 2007, most recently 2011-03-16.
CIK 0001350855
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $15.0M since 2007, against 2 sales. Across 6 scored buys the stock is up 1.1% at ninety days, and 0.9 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +18.4% | +1.1% | +1.1% |
| Alpha | -34.8% | +0.9% | +0.9% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AOLS | SELL | 2011-03-15 | 2011-03-17 | $0.62 | $2.5M | N/A | N/A | N/A |
| RPRX | SELL | 2009-12-17 | 2009-12-21 | $0.67 | $105K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-10-23 | 2008-10-27 | $6.72 | $418K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-10-10 | 2008-10-14 | $6.52 | $198K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-10-02 | 2008-10-06 | $6.50 | $12.0M | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2008-02-28 | 2008-03-03 | $8.30 | $415K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2007-12-28 | 2008-01-02 | $9.37 | $1.2M | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2007-12-18 | 2007-12-20 | $9.82 | $840K | +18.4% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.